AccScience Publishing / EJMO / Online First / DOI: 10.36922/EJMO025150106
Submit to EJMO
Cite this article
6
Download
47
Views
Journal Browser
Volume | Year
Issue
Search
Forthcoming Issue
Current Issue
View All
News and Announcements
View All
ORIGINAL RESEARCH ARTICLE

Revisiting the role of the Pfannenstiel incision in early-stage endometrial cancer

Cem Yagmur Ozdemir1,2* ,  Hasan Eroğlu3 ,  Necat Cağatay Sezer3 ,  Nayif Çicekli2,4 ,  Derya Yeğin Aksu5 ,  Dağıstan Tolga Arioz2
Show Less
1 Department of Gynecological Oncology, Afyonkarahisar State Hospital, Afyonkarahisar, Turkey
2 Department of Gynecological Oncology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey
3 Department of Gynecology and Obstetrics, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey
4 Department of Gynecological Oncology, Erzurum City Hospital, Erzurum, Turkey
5 Department of Pathology, Faculty of Medicine, Afyonkarahisar Health Sciences University, Afyonkarahisar, Turkey
EJMO, 025150106 https://doi.org/10.36922/EJMO025150106
Received: 11 April 2025 | Revised: 7 May 2025 | Accepted: 27 May 2025 | Published online: 19 June 2025
© 2025 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution -Noncommercial 4.0 International License (CC-by the license) ( https://creativecommons.org/licenses/by-nc/4.0/ )
Download PDF
Cite
XML
Abstract

Introduction: Endometrial cancer is the most common gynecologic malignancy in developed countries, and the optimal surgical approach in early-stage cases remains a subject of ongoing clinical debate. Objective: This study aims to compare laparoscopy and Pfannenstiel incision in early-stage, low-grade endometrial cancer (EC) surgery. Methods: A retrospective study was conducted on the records of 224 patients diagnosed with EC between April 2010 and April 2024. Only patients with stage I and grade I-II endometrioid type EC were included in the study. After excluding 94 patients with non-endometrioid histology, stage II-IV disease, grade 3 tumors, and synchronous tumors, 130 patients were included in the final analysis. Participants were categorized into two groups: Group 1 (63 patients who underwent surgery through Pfannenstiel incision) and Group 2 (67 patients who underwent laparoscopic surgery). Results: The median overall survival (OS) was 48 months (range: 12 – 168) and the median disease-free survival (DFS) was 47 months (range: 8 – 168). During the follow-up period, 20 patients died and 8 patients experienced disease recurrence. The overall OS rate was 84.6%, and the DFS was 93.8%. When comparing groups, the OS was 85.7% in Group 1 and 83.6% in Group 2 (p=0.12). The DFS rate was significantly higher in Group 1 compared to Group 2 (96.8% vs. 91%; p=0.037). Conclusion: This study highlights the continued relevance of staging surgery with the Pfannenstiel incision in early-stage EC patients with vaginal stenosis, morbid obesity unsuitable for trocar insertion, a history of multiple abdominal surgeries, inability to insert a manipulator, an enlarged normal uterus, or suspected pelvic adhesions.

Keywords
Endometrial cancer
Laparoscopy
Pfannenstiel incision
Funding
None.
Conflict of interest
The authors declare no competing interests.
References
  1. Crosbie EJ, Kitson SJ, McAlpine JN, Mukhopadhyay A, Powell ME, Singh N. Endometrial cancer. Lancet. 2022;399(10333):1412-1428. doi: 10.1016/S0140-6736(22)00323-3

 

  1. Kalampokas E, Giannis G, Kalampokas T, et al. Current approaches to the management of patients with endometrial cancer. Cancers (Basel). 2022;14(18):4500. doi: 10.3390/cancers14184500

 

  1. Bilir F, Arıoz DT, Arıkan SE, et al. Relationship between molecular markers and lymphadenectomy and lymphovascular space invasion in endometrial cancer. Arch Gynecol Obstet. 2023;308(3):941-946. doi: 10.1007/s00404-023-07005-9

 

  1. Natarajan P, Delanerolle G, Dobson L, et al. Surgical treatment for endometrial cancer, hysterectomy performed via minimally invasive routes compared with open surgery: A systematic review and network meta-analysis. Cancers (Basel). 2024;16(10):1860. doi: 10.3390/cancers16101860

 

  1. Patel N, Chaudhari K, Jyotsna G, Joshi JS. Surgical frontiers: A comparative review of robotics versus laparoscopy in gynecological interventions. Cureus. 2023;15(11):e49752. doi: 10.7759/cureus.49752

 

  1. Giannini A, D’Oria O, Vizza E, et al. Robotic-assisted, laparoscopic, and vaginal hysterectomy in morbidly obese patients with endometrial hyperplasia and endometrial cancer. Minim Invasive Ther Allied Technol. 2024;33:358-364. doi: 10.1080/13645706.2024.2407845

 

  1. Montgomery A, Van Eeden L, Boo M, et al. Does closed incision negative pressure wound therapy reduce surgical site infection in endometrial carcinoma patients undergoing laparotomy? A multicentre retrospective cohort study. Clin Exp Obstet Gynecol. 2023;50(5):102. doi: 10.31083/j.ceog5005102

 

  1. Al-Majali J, Qasem M, Al-Ani A, et al. 635 transverse versus midline abdominopelvic incisions: A systematic review. Int J Gynecol Cancer. 2021;31(Suppl 3):A36-A36. doi: 10.1136/ijgc-2021-ESGO.52

 

  1. Ayhan A, Dursun P, Gultekin M, Esin S. Pfannenstiel vs. Midline incision for early stage endometrial carcinoma. Int J Gynecol Obstet. 2006;93(1):67-69. doi: 10.1016/j.ijgo.2005.12.029

 

  1. Rady HA, Mohammed NE, Ragab MH. Lower midline versus pfannenstiel incision in pelvic lymphadenectomy in endometrial cancer. Indian J Gynecol Oncol. 2019;17:36.

 

  1. Tzenios N, Chahine M, Tazanios M. Obesity and endometrial cancer: The role insulin resistance and adipokines. Special J Med Acad Other Life Sci. 2023;1(2). doi: 10.58676/sjmas.v1i2.12

 

  1. Skolnik E, Miazga E, Zakhari A, Cai E, Ziegler C, Murji A. Beyond the pfannenstiel: Minimally invasive laparotomy incisions for maximum exposure. J Obstet Gynaecol Can. 2021;43(3):368. doi: 10.1016/j.jogc.2020.10.013

 

  1. Vaezi M, Zarei R, Azizi H. Comparison of maylard and cherney incisions’ outcomes in hysterectomy surgery for benign indications: A double-blind randomized controlled trial. Eur J Med Res. 2025;30(1):56. doi: 10.1186/s40001-025-02311-1

 

  1. Güven E, Dura MC, Aktürk H, Güraslan H. Safety of laparoscopic entry points in patients with a history of abdominal surgery: A research article. Cureus. 2023;15(10):e47244. doi: 10.7759/cureus.47244

 

  1. Matsuo K, Sood AK, Gershenson DM. Management of early-stage ovarian cancer. In: Surgery for Ovarian Cancer. United States: CRC Press; 2022. p. 60-92.

 

  1. Polen-De C, Bakkum-Gamez J, Langstraat C. Route of hysterectomy for benign disease: Abdominal hysterectomy. J Gynecol Surg. 2021;37(2):116-121. doi: 10.1089/gyn.2021.0002

 

  1. Abdelazim I, AbuFaza M. Pfannenstiel incision for surgical excision of a huge pelvi-abdominal cystadenoma: A case report. Prz Menopauzalny. 2021;20(2):99-102. doi: 10.5114/pm.2021.106469

 

  1. Habib AS, Wahl K, Gu J, Gan TJ, Adenosine Study Group. Comparison of postoperative pain outcomes after vertical or Pfannenstiel incision for major gynecologic surgery. Curr Med Res Opin. 2009;25(6):1529-1534. doi: 10.1185/03007990902959168

 

  1. Lewin SN, Herzog TJ, Medel NI, et al. Comparative performance of the 2009 international federation of gynecology and obstetrics’ staging system for uterine corpus cancer. Obstet Gynecol. 2010;116(5):1141-1149. doi: 10.1097/AOG.0b013e3181f39849

 

  1. Bogani G, Ray-Coquard I, Concin N, et al. Clear cell carcinoma of the endometrium. Gynecol Oncol. 2022;164(3):658-666. doi: 10.1016/j.ygyno.2022.01.012

 

  1. Hasson HM. A modified instrument and method for laparoscopy. Am J Obstet Gynecol. 1971;110:886-887. doi: 10.1016/0002-9378(71)90593-x

 

  1. Fathi A, Saleh MM, Shetiwy M, et al. Operative outcomes of single-incision laparoscopic hysterectomy vs conventional laparoscopic total hysterectomy: A prospective randomized controlled study. Surg Innov. 2022;29(5):590-599. doi: 10.1177/15533506211041892

 

  1. McCurdy RJ, Harding S, Felder L, Beáta A, Schnatz P, Berghella V. Cohen vs Pfannenstiel cesarean skin incision for body mass index ≥35 kg/m2: A randomized controlled trial. Am J Obstet Gynecol MFM. 2024;6(12):101528. doi: 10.1016/j.ajogmf.2024.101528

 

  1. Januszek SM, Wita-Popow B, Kluz M, et al. Risk factors for surgical treatment of endometrial cancer using traditional and laparoscopic methods. J Clin Med. 2021;10(3):429. doi: 10.3390/jcm10030429

 

  1. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105:103-104. doi: 10.1016/j.ijgo.2009.02.012

 

  1. Berek JS, Matias‐Guiu X, Creutzberg C, et al. FIGO staging of endometrial cancer: 2023. Int J Gynecol Obstet. 2023;162(2):383-394. doi: 10.1002/ijgo.14923

 

  1. Pergialiotis V, Panagiotopoulos M, Koutras A, et al. The impact of positive peritoneal cytology on the survival rates of early-stage-disease endometrial cancer patients: Systematic review and meta-analysis. Medicina. 2024;60(5):733.doi: 10.3390/medicina60050733

 

  1. Takenaka M, Kamii M, Iida Y, et al. Re-thinking the prognostic significance of positive peritoneal cytology in endometrial cancer. Gynecol Oncol. 2021;161(1):135-142. doi: 10.1016/j.ygyno.2021.01.007

 

  1. Padilla-Iserte P, Lago V, Tauste C, et al. Impact of uterine manipulator on oncological outcome in endometrial cancer surgery. Am J Obstet Gynecol. 2021;224:65-e1.e11. doi: 10.1016/j.ajog.2020.07.025

 

  1. Machida H, Hom MS, Adams CL, et al. Intrauterine manipulator use during minimally invasive hysterectomy and risk of lymphovascular space invasion in endometrial cancer. Int J Gynecol Cancer. 2018;28(2):208-219. doi: 10.1097/IGC.0000000000001181

 

  1. Matsuo K, Klar M, Nusbaum DJ, et al. Utilization and outcomes of sentinel lymph node biopsy for early endometrial cancer. Obstet Gynecol. 2022;139(5):809-820. doi: 10.1097/AOG.0000000000004733

 

  1. Raffone A, Fanfani F, Raimondo D, et al. Predictive factors of sentinel lymph node failed mapping in endometrial carcinoma patients: A systematic review and meta-analysis. Int J Gynecol Cancer. 2023;33(6):853-859. doi: 10.1136/ijgc-2022-004014

 

  1. Baiocchi G, Andrade CEMC, Ribeiro R, et al. Sentinel lymph node mapping versus sentinel lymph node mapping with systematic lymphadenectomy in endometrial cancer: An open-label, non-inferiority, randomized trial (ALICE trial). Int J Gynecol Cancer. 2022;32(5):676-679. doi: 10.1136/ijgc-2022-003378

 

  1. Zammarrelli WA 3rd., Afonso AM, Broach V, et al. Sentinel lymph node biopsy in patients with endometrial cancer and an indocyanine green or iodinated contrast reaction-a proposed management algorithm. Gynecol Oncol. 2021;162(2):262-267. doi: 10.1016/j.ygyno.2021.05.009

 

  1. Segarra B, Meyer LA, Malpica A, Bhosale P. Endometrial cancer recurrence at multiple port sites. Int J Gynecol Cancer. 2020;30(6):893-896. doi: 10.1136/ijgc-2020-001327

 

  1. Frumovitz M, Obermair A, Coleman RL, et al. Quality of life in patients with cervical cancer after open versus minimally invasive radical hysterectomy (LACC): A secondary outcome of a multicentre, randomised, open-label, phase 3, non-inferiority trial. Lancet Oncol. 2020;21(6):851-860. doi: 10.1016/S1470-2045(20)30081-4

 

  1. Gultekin M, Dundar S, Kucukyildiz I, et al. Survival of gynecological cancers in Turkey: Where are we at? J Gynecol Oncol. 2017;28(6):e85. doi: 10.3802/jgo.2017.28.e85

 

  1. Kurosu H, Todo Y, Yamada R, et al. A BMI-category distribution pattern of intrinsic and treatment-related prognostic factors in endometrial cancer. Jpn J Clin Oncol. 2021;51(5):722-727. doi: 10.1093/jjco/hyaa274

 

  1. Stuart GC, Kitchener H, Bacon M, et al. 2010 gynecologic cancer intergroup (GCIG) consensus statement on clinical trials in ovarian cancer: Report from the fourth ovarian cancer consensus conference. Int J Gynecol Cancer. 2011;21:750-755. doi: 10.1097/IGC.0b013e31821b2568

 

  1. Alouini S, Bakri Y. Para-aortic lymphadenectomy in ovarian, endometrial, gastric, and bladder cancers: A systematic review of randomized controlled trials. Cancers (Basel). 2024;16(19):3394. doi: 10.3390/cancers16193394

 

  1. Ronsini C, Iavarone I, Vastarella MG, et al. SIR-EN-new biomarker for identifying patients at risk of endometrial carcinoma in abnormal uterine bleeding at menopause. Cancers (Basel). 2024;16(21):3567. doi: 10.3390/cancers16213567

 

  1. Lubiński J, Lener MR, Marciniak W, et al. Serum essential elements and survival after cancer diagnosis. Nutrients. 2023;15(11):2611. doi: 10.3390/nu15112611
Next article in this issue
Share
Back to top
Eurasian Journal of Medicine and Oncology, Electronic ISSN: 2587-196X Print ISSN: 2587-2400, Published by AccScience Publishing
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here
Accept